Crossmark

Integration of single-cell and bulk RNA sequencing to identify a distinct tumor stem cells and construct a novel prognostic signature for evaluating prognosis and immunotherapy in LUAD

Crossref DOI link: https://doi.org/10.1186/s12967-025-06243-6

Published Online: 2025-02-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Fengyun https://orcid.org/0000-0003-2266-066X
Chen, Mengting

Wu, Tianjiao

Ji, Mingfang

Li, Fugui
License Information

Text and Data Mining valid from 2025-02-22

Version of Record valid from 2025-02-22
More Information

Article History

Received: 18 December 2024

Accepted: 11 February 2025

First Online: 22 February 2025

Declarations

:

: The protocol and all procedures involving human samples in this study were reviewed and approved by the Institutional Review Board (IRB) of Zhongshan City People's Hospital (approval number: 2024–116). Informed patient consent was obtained from all individuals whose paraffin-embedded tissues were used in this study. All research procedures were conducted in compliance with relevant ethical guidelines and local laws.

: Not appliable.

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below